citric acid, anhydrous has been researched along with Myocardial Ischemia in 8 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Magnesium depletion and hypomagnesemia are common among furosemide-treated patients with chronic congestive heart failure." | 7.70 | Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure. ( Almoznino-Sarafian, D; Alon, I; Berman, S; Cohen, N; Golik, A; Gorelik, O; Modai, D; Weissgarten, J; Zaidenstein, R, 2000) |
| "Magnesium depletion and hypomagnesemia are common among furosemide-treated patients with chronic congestive heart failure." | 3.70 | Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure. ( Almoznino-Sarafian, D; Alon, I; Berman, S; Cohen, N; Golik, A; Gorelik, O; Modai, D; Weissgarten, J; Zaidenstein, R, 2000) |
| "Recognition of myocardial ischemia is critical both for the diagnosis of coronary artery disease and the selection and evaluation of therapy." | 1.33 | Metabolomic identification of novel biomarkers of myocardial ischemia. ( Berriz, GF; Gerszten, RE; Heller, E; Liu, E; McCarroll, R; Morrow, DA; Roth, FP; Sabatine, MS; Wiegand, R, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Järveläinen, N | 1 |
| Halonen, P | 1 |
| Nurro, J | 1 |
| Hätinen, OP | 1 |
| Korpela, H | 1 |
| Mäkinen, P | 1 |
| Gan, LM | 1 |
| Fritsche-Danielson, R | 1 |
| Ylä-Herttuala, S | 1 |
| Schroeder, MA | 1 |
| Atherton, HJ | 1 |
| Ball, DR | 1 |
| Cole, MA | 1 |
| Heather, LC | 1 |
| Griffin, JL | 1 |
| Clarke, K | 1 |
| Radda, GK | 1 |
| Tyler, DJ | 1 |
| Comte, B | 1 |
| Vincent, G | 1 |
| Bouchard, B | 1 |
| Benderdour, M | 1 |
| Des Rosiers, C | 1 |
| Monti, LD | 1 |
| Setola, E | 1 |
| Fragasso, G | 1 |
| Camisasca, RP | 1 |
| Lucotti, P | 1 |
| Galluccio, E | 1 |
| Origgi, A | 1 |
| Margonato, A | 1 |
| Piatti, P | 1 |
| Sabatine, MS | 1 |
| Liu, E | 1 |
| Morrow, DA | 1 |
| Heller, E | 1 |
| McCarroll, R | 1 |
| Wiegand, R | 1 |
| Berriz, GF | 1 |
| Roth, FP | 1 |
| Gerszten, RE | 1 |
| Makeeva, AV | 1 |
| Popova, TN | 1 |
| Matasova, LV | 1 |
| Yama, IN | 1 |
| Hassel, B | 1 |
| Ilebekk, A | 1 |
| Tønnessen, T | 1 |
| Cohen, N | 1 |
| Alon, I | 1 |
| Almoznino-Sarafian, D | 1 |
| Zaidenstein, R | 1 |
| Weissgarten, J | 1 |
| Gorelik, O | 1 |
| Berman, S | 1 |
| Modai, D | 1 |
| Golik, A | 1 |
1 trial available for citric acid, anhydrous and Myocardial Ischemia
| Article | Year |
|---|---|
Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy.
Topics: 3-Hydroxybutyric Acid; Aged; Blood Glucose; Citric Acid; Cross-Over Studies; Cyclic GMP; Diabetes Me | 2006 |
7 other studies available for citric acid, anhydrous and Myocardial Ischemia
| Article | Year |
|---|---|
Citrate-Saline-Formulated mRNA Delivery into the Heart Muscle with an Electromechanical Mapping and Injection Catheter Does Not Lead to Therapeutic Effects in a Porcine Chronic Myocardial Ischemia Model.
Topics: Animals; Catheters; Citric Acid; Myocardial Ischemia; Myocardium; RNA, Messenger; Stroke Volume; Swi | 2021 |
Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy.
Topics: Acetylcarnitine; Animals; Carbon Isotopes; Citric Acid; Citric Acid Cycle; Energy Metabolism; Glutam | 2009 |
Reverse flux through cardiac NADP(+)-isocitrate dehydrogenase under normoxia and ischemia.
Topics: Aconitate Hydratase; Animals; Carbon Isotopes; Citrate (si)-Synthase; Citric Acid; Citric Acid Cycle | 2002 |
Metabolomic identification of novel biomarkers of myocardial ischemia.
Topics: Adenosine Monophosphate; Aged; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liqui | 2005 |
Effects of lipoic acid on citrate content, aconitate hydratase activity, and oxidative status during myocardial ischemia in rats.
Topics: Aconitate Hydratase; Animals; Antioxidants; Citric Acid; Male; Myocardial Ischemia; Myocardium; Oxid | 2008 |
Cardiac accumulation of citrate during brief myocardial ischaemia and reperfusion in the pig in vivo.
Topics: Amino Acids; Ammonia; Animals; Biopsy; Citric Acid; Female; Glucose; Hemodynamics; Male; Myocardial | 1998 |
Metabolic and clinical effects of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Cardiomyopathy, Dilated; Citric Acid; Dietary Supplements; Diuret | 2000 |